BDBM50426450 CHEMBL2322664

SMILES N[C@@H](Cc1ccccc1)C(=O)N1CCN(CC1)c1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1

InChI Key InChIKey=VOPWCDJBVPMVLJ-FQEVSTJZSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 50426450   

TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Monash University

Curated by ChEMBL
LigandPNGBDBM50426450(CHEMBL2322664)
Affinity DataIC50:  2.80E+3nMAssay Description:Inhibition of PI3Kbeta in human platelet-rich plasma assessed as suppression of ADP-induced platelet aggregation preincubated for 5 mins followed by ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Monash University

Curated by ChEMBL
LigandPNGBDBM50426450(CHEMBL2322664)
Affinity DataIC50:  30nMAssay Description:Inhibition of PI3Kbeta in human washed platelets assessed as suppression of ADP-induced platelet aggregation preincubated for 5 mins followed by ADP ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Monash University (Parkville Campus)

Curated by ChEMBL
LigandPNGBDBM50426450(CHEMBL2322664)
Affinity DataIC50:  2.20E+3nMAssay Description:Inhibition of PI3K-delta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Monash University (Parkville Campus)

Curated by ChEMBL
LigandPNGBDBM50426450(CHEMBL2322664)
Affinity DataIC50:  1.20E+4nMAssay Description:Inhibition of wild type PI3K-alpha (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 100 uM ATP as...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Monash University

Curated by ChEMBL
LigandPNGBDBM50426450(CHEMBL2322664)
Affinity DataIC50:  63nMAssay Description:Inhibition of PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate m...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Monash University (Parkville Campus)

Curated by ChEMBL
LigandPNGBDBM50426450(CHEMBL2322664)
Affinity DataIC50:  4.70E+3nMAssay Description:Inhibition of PI3K-alpha (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Monash University

Curated by ChEMBL
LigandPNGBDBM50426450(CHEMBL2322664)
Affinity DataIC50:  74nMAssay Description:Inhibition of wild type PI3K-beta (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 100 uM ATP as ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Monash University (Parkville Campus)

Curated by ChEMBL
LigandPNGBDBM50426450(CHEMBL2322664)
Affinity DataIC50:  1.00E+5nMAssay Description:Inhibition of PI3K-gamma (unknown origin) assessed as decrease in ATP consumption using phosphotidylinositol bisphosphate and 10 uM ATP as substrate ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed